C oronary artery disease accounts for ≈1 in every 6 deaths in the United States, with acute ST-segment-elevation myocardial infarction (STEMI) contributing significantly to the overall morbidity associated with this disease. 1 Postmortem studies in patients dying of myocardial infarction consistently demonstrate that the majority of STEMIs are triggered by rupture of a thin-fibrous cap overlying a lipidrich necrotic core.
C oronary artery disease accounts for ≈1 in every 6 deaths in the United States, with acute ST-segment-elevation myocardial infarction (STEMI) contributing significantly to the overall morbidity associated with this disease. 1 Postmortem studies in patients dying of myocardial infarction consistently demonstrate that the majority of STEMIs are triggered by rupture of a thin-fibrous cap overlying a lipidrich necrotic core. [2] [3] [4] [5] Intracoronary near-infrared spectroscopy (NIRS) is a catheter-based imaging modality developed and validated to detect lipid-rich plaques (LRPs) in patients undergoing coronary angiography. 6, 7 In an exploratory analysis in a small number of STEMI patients, NIRS demonstrated large, significant differences in the lipid content between culprit and nonculprit segments. 8 A potential NIRS signature of STEMI culprit lesions was identified, defined by a maximum lipid core burden index within a 4-mm coronary section (maxL-CBI 4mm ) being >400. These initial observations were limited by a modest sample size, single-center enrollment, and post hoc selection of the maxLCBI 4mm ≥400 threshold. This study was designed a priori to confirm the ability of NIRS to discriminate STEMI culprit from nonculprit segments and to determine the sensitivity and specificity of the maxLCBI 4mm ≥400 threshold. Secondary aims were to evaluate the ability of the NIRS block chemogram to differentiate culprit from nonculprit segments and to evaluate the regional deposition of lipid within coronary segments adjacent to the angiographically defined culprit segment.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement (Figure 1 ).
Results

Study Population
Between July 2012 and May 2013, NIRS-IVUS imaging was performed within the culprit vessel of 79 patients experiencing STEMI at the 2 participating centers. Of these, 4 patients were excluded because of uninterpretable NIRS images. The remaining 75 patients constitute the study population, all of whom had a single culprit lesion. Table 1 describes the baseline characteristics of the study population, including culprit lesion location, initial thrombolysis in myocardial infarction flow grade, and method used to establish thrombolysis in myocardial infarction 3 flow before NIRS-IVUS imaging.
NIRS Findings in STEMI Culprit Vessels
NIRS frequently identified a large, nearly circumferential LRP at the STEMI culprit site (Figure 2 Figure 3 ). By receiver-operating characteristic analysis, maxLCBI 4mm identified STEMI culprit segments accurately against a background of nonculprit segments (c-statistic=0.83, P<0.001; Figure 4) . A threshold maxLCBI 4mm ≥400 distinguished STEMI culprit from nonculprit segments with a sensitivity of 64% and a specificity of 85%. The sensitivity and specificity of various maxLCBI 4mm thresholds are provided in Table 2 . culprit segments with a sensitivity of 83% and a specificity of 60%. Figure 4 ). With respect to differentiating STEMI culprit segments from nonculprit segments, maxLCBI 4mm performed similar to PB (P=0.50) and both maxLCBI 4mm and PB were significantly more discriminatory for STEMI culprit segments than calcification by IVUS (P<0.001 for both). Although maxLCBI 4mm , PB, and calcification were all significantly associated with STEMI culprit segments by univariate analysis, maxLCBI 4mm and PB were the only significant predictors of STEMI culprit segments by multivariable analysis (P values in multivariable model <0.001, <0.001, and 0.54, respectively).
NIRS Block Chemogram Analysis in STEMI Culprit Vessels
IVUS Findings in STEMI Culprit Segments
Regional Deposition of Lipid in Segments Immediately Adjacent to the Angiographic Culprit Lesion
Among the 27 cases in which NIRS did not identify a maxL-CBI 4mm ≥400 within the 10-mm angiographic culprit segment, NIRS detected a maxLCBI 4mm ≥400 within a 10-mm segment immediately adjacent to the angiographic culprit segment in 8 (29.6%) cases. Overall, NIRS detected a maxLCBI 4mm ≥400 in the angiographic culprit segment or in the adjacent 10-mm segments in 56 (75.0%) of 75 cases. A maxLCBI 4mm ≥400 was detected more often in the 10-mm segments immediately adjacent to the culprit segment compared with all other nonculprit segments (adjacent 18% versus all other nonculprit 11%, P=0.10).
Discussion
This study, designed to investigate previous NIRS observations in STEMI, 8 confirms the significant discriminatory capacity of maxLCBI 4mm to identify STEMI culprit segments and substantiates that a maxLCBI 4mm ≥400 is detected by NIRS at the majority of STEMI culprit sites. Given that the LRP generating the maxLCBI 4mm ≥400 signal was likely present in the artery before the onset of myocardial infarction, these results support ongoing prospective studies testing the capacity of NIRS imaging to predict site-specific future acute coronary events. 9 In addition to these confirmatory observations, 2 novel observations were made in this study. First, the presence of LRP on the NIRS block chemogram was found to significantly discriminate culprit from nonculprit segments in STEMI, yet not as robustly as the maxLCBI 4mm metric. This observation suggests that the size of an LRP rather than its mere presence may have important implications in the pathogenesis of myocardial infarction. Second, NIRS was shown for the first time to detect a clustering of LRP in the region surrounding the angiographic culprit segment. This finding suggests that NIRS imaging might be useful as an adjunct to traditional angiography in STEMI patients to confirm the true location of the culprit lesion before stenting.
Sensitivity and Specificity of the MaxLCBI 4mm ≥400 Threshold
This study confirms a relatively high specificity of the max-LCBI 4mm ≥400 threshold for identifying STEMI culprit segments. Although our previous NIRS study of STEMI culprit vessels identified a maxLCBI 4mm ≥400 in 85% of culprit segments, 8 NIRS detected the presence of an LRP in 83% and a maxLCBI4 mm ≥400 in 64% of STEMI culprit sites in this study. These findings are consistent with postmortem observations implicating rupture of an LRP as the pathogenesis for roughly two thirds of fatal myocardial infarctions. [2] [3] [4] [5] Although a large LRP having a maxLCBI 4mm ≥400 was found in 64% of culprit sites in this study, an LRP of any size was detected by NIRS in 83% of STEMI culprit segments. A similarly high prevalence of LRP detected by NIRS at culprit sites has been previously reported in a population of patients consisting mostly of non-ST-segment-elevation acute coronary syndromes. 10 At first glance, this high prevalence of LRP at culprit sites is seemingly inconsistent with the concept established by autopsy studies that only two thirds of myocardial infarctions are triggered by rupture of an LRP. [2] [3] [4] [5] However, lesions triggering myocardial infarction via plaque erosion rather than rupture frequently contain lipid pools, a lipid accumulation in which cellular structure is intact. 4, 11 Hence, this apparent LRP-culprit lesion paradox, in which >80% of culprit lesions in this study contained an LRP, may be partially explained by the high sensitivity of NIRS to simply detect coronary arterial lipid within lesions triggering myocardial infarction regardless of the whether the underlying mechanism is that of rupture of a plaque containing a lipid core or plaque erosion above a lipid pool. The ability of NIRS imaging to identify lipid pools was shown to be the cause of false positives when NIRS imaging was tested for its ability to detect lipid cores. 6 Although it is possible that culprit lesions lacking a large lipid burden in this study may have triggered thrombosis via erosion rather than rupture, the current NIRS-IVUS technology lacks the spatial resolution to differentiate rupture from erosion, a limitation that may be overcome by the introduction of high-definition IVUS imaging or by additional imaging with optical coherence tomography.
12,13
NIRS as an Adjunct for Culprit Lesion Localization
In nearly one third of cases in which a large LRP was not present within the angiographically defined culprit segment, a large LRP was detected by NIRS in a segment of vessel immediately adjacent to the angiographic culprit segment. In such cases, we propose that the thrombus may have formed at the site of the large LRP, and then either migrated downstream in the direction of blood flow or propagated proximally, thereby transposing the proximal angiographic culprit margin away from the original source of thrombus formation.
14 Future studies are needed to determine whether NIRS-guided stenting, which might improve localization of the true culprit lesion, could improve outcomes compared with traditional angiography-guided stenting in STEMI.
Lipid Burden or PB to Identify Culprit Lesions
Consistent with a previous NIRS-IVUS analysis in STEMI, 8 this study demonstrated that maxLCBI 4mm on NIRS and PB on IVUS discriminated culprit from nonculprit segments with similar accuracy. It is not known whether the initial plaque rupture event likely underlying many of these cases resulted in some of the culprit lesion lipid content being released into the circulation, thereby reducing the measured maxLCBI 4mm . It is also not known whether thrombus at the culprit site may have been inadvertently mistaken for plaque, thereby increasing the measured PB. Prospective studies are required to determine whether maxLCBI 4mm or PB, or a combination of both characteristics will serve best in identifying coronary lesions likely to trigger future acute coronary events.
Limitations
NIRS images were recorded after establishing thrombolysis in myocardial infarction 3 flow with either balloon angioplasty or aspiration thrombectomy. These processes, as well as an initial plaque rupture event, may have liberated lipid into coronary blood flow thereby reducing the maxLCBI 4mm of the culprit lesion and the likelihood that the culprit lesion contained a bright yellow block on the NIRS block chemogram. 15 Such processes would be expected to bias the comparison of lipid content of culprit and nonculprit segments toward the null. To be consistent with a previous NIRS analysis in STEMI patients, 8 the present methodology limited culprit segments to only 10 mm in length. This approach is supported by pathological evidence that the average length of ruptured necrotic cores and thin-capped fibroatheromas is <10 mm. 16 Nonculprit lesions located outside of the culprit vessel were not imaged in this study and were, therefore, not included in the analysis. The impact of including all nonculprit segments, rather than only those in the culprit vessel, remains unclear and will require future study. Finally, the present results were recorded in a cross-sectional manner at the time of STEMI presentation. Given that the maxLCBI 4mm ≥400 threshold was measured after the acute thrombotic event and after minor plaque modification for re-establishing coronary flow, the maxLCBI 4mm ≥400 threshold may be lower than the optimal threshold to test in prospective studies. The optimal NIRS findings that may be predictive of future acute coronary events will be evaluated in the large-scale multicenter prospective NIRS studies currently in progress. 9 
Conclusions
This study substantiates the discriminatory capacity of intracoronary NIRS imaging to accurately differentiate STEMI culprit from nonculprit segments using the maxLCBI 4mm metric. In addition to detecting large differences in the lipid burden of culprit and nonculprit segments, this study confirms that NIRS detects a maxLCBI 4mm ≥400 in the majority of STEMI culprit sites. These findings support ongoing prospective studies evaluating the use of intracoronary NIRS imaging to provide site-specific prediction of future acute coronary events. In a previous exploratory analysis, intracoronary near-infrared spectroscopy found the majority of culprit lesions in ST-segment-elevation myocardial infarction had a maximum lipid core burden index in 4 mm ≥400. However, this previous single-center study was limited by a small sample size and post hoc selection of the maximum lipid core burden index in 4 mm ≥400 threshold. By studying ST-segmentelevation myocardial infarction patients prospectively enrolled at 2 centers in the United States and Sweden, this study substantiates the ability of near-infrared spectroscopy to accurately differentiate ST-segment-elevation myocardial infarction culprit from nonculprit segments and confirms that a threshold maximum lipid core burden index in 4 mm ≥400 is detected by near-infrared spectroscopy in the majority of ST-segment-elevation myocardial infarction culprits. Given that the lipid core generating the maximum lipid core burden index in 4 mm ≥400 signal was likely present in the artery before the onset of myocardial infarction, these results support ongoing prospective studies testing the predictive capacity of near-infrared spectroscopy imaging for future site-specific acute coronary events.
Sources of Funding
Significance
